SANUWAVE Health (SANUWAVE Health) Risk Assessment

View and export this data going back to 2008. Start your Free Trial

What is SANUWAVE Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SANUWAVE Health is: No Data: Cannot be evaluated.

Competitive Comparison of SANUWAVE Health's Risk Assessment

For the Medical Devices subindustry, SANUWAVE Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SANUWAVE Health's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Risk Assessment falls into.

SANUWAVE Health (OTCPK:SNWV) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

SANUWAVE Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

SANUWAVE Health (SANUWAVE Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

11495 Valley View Road, Eden Prairie, MN, USA, 30024

Website

https://www.sanuwave.com

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Executives

Andrew Walko	officer: President	11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
James E Besser	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p.	director, other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank	director	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price	director	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh	officer: President	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii	10 percent owner	200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski	director	99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc.	director	3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom	officer: Interim CFO	11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli	director, officer: Chief Executive Officer	510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins	officer: Chief Financial Officer	11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino	director	PO BOX 376, LOBBY L., ANN ARBOR MI 48105